These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 24487434)

  • 1. Fas ligand-mediated immune surveillance by T cells is essential for the control of spontaneous B cell lymphomas.
    Afshar-Sterle S; Zotos D; Bernard NJ; Scherger AK; Rödling L; Alsop AE; Walker J; Masson F; Belz GT; Corcoran LM; O'Reilly LA; Strasser A; Smyth MJ; Johnstone R; Tarlinton DM; Nutt SL; Kallies A
    Nat Med; 2014 Mar; 20(3):283-90. PubMed ID: 24487434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cells prevent the development of spontaneous B-cell lymphomas.
    Cancer Discov; 2014 Apr; 4(4):OF14. PubMed ID: 24706665
    [No Abstract]   [Full Text] [Related]  

  • 3. BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma.
    Mandelbaum J; Bhagat G; Tang H; Mo T; Brahmachary M; Shen Q; Chadburn A; Rajewsky K; Tarakhovsky A; Pasqualucci L; Dalla-Favera R
    Cancer Cell; 2010 Dec; 18(6):568-79. PubMed ID: 21156281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AID-associated DNA repair pathways regulate malignant transformation in a murine model of BCL6-driven diffuse large B-cell lymphoma.
    Gu X; Booth CJ; Liu Z; Strout MP
    Blood; 2016 Jan; 127(1):102-12. PubMed ID: 26385350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRDM1/BLIMP1: a tumor suppressor gene in B and T cell lymphomas.
    Boi M; Zucca E; Inghirami G; Bertoni F
    Leuk Lymphoma; 2015 May; 56(5):1223-8. PubMed ID: 25115512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma.
    Pasqualucci L; Compagno M; Houldsworth J; Monti S; Grunn A; Nandula SV; Aster JC; Murty VV; Shipp MA; Dalla-Favera R
    J Exp Med; 2006 Feb; 203(2):311-7. PubMed ID: 16492805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms.
    Parekh S; Polo JM; Shaknovich R; Juszczynski P; Lev P; Ranuncolo SM; Yin Y; Klein U; Cattoretti G; Dalla Favera R; Shipp MA; Melnick A
    Blood; 2007 Sep; 110(6):2067-74. PubMed ID: 17545502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic activity of Card11 mutant and Bcl6 in the development of diffuse large B-cell lymphoma in a mouse model.
    Takahara T; Matsuo K; Seto M; Nakamura S; Tsuzuki S
    Cancer Sci; 2016 Nov; 107(11):1572-1580. PubMed ID: 27560392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fas and Fas ligand expression on germinal center type-diffuse large B-cell lymphoma is associated with the clinical outcome.
    Kojima Y; Tsurumi H; Goto N; Shimizu M; Kasahara S; Yamada T; Kanemura N; Hara T; Sawada M; Saio M; Yamada T; Takahashi T; Tomita E; Takami T; Moriwaki H
    Eur J Haematol; 2006 Jun; 76(6):465-72. PubMed ID: 16494623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Impact of PRDM1 gene inactivation on C-MYC regulation in diffuse large B-cell lymphoma].
    Zhang XY; Ma ZP; Cui WL; Pang XL; Chen R; Wang L; Zhang W; Li XX
    Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):25-31. PubMed ID: 29325247
    [No Abstract]   [Full Text] [Related]  

  • 11. Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma.
    Pasqualucci L; Migliazza A; Basso K; Houldsworth J; Chaganti RS; Dalla-Favera R
    Blood; 2003 Apr; 101(8):2914-23. PubMed ID: 12515714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomas.
    Pascual M; Mena-Varas M; Robles EF; Garcia-Barchino MJ; Panizo C; Hervas-Stubbs S; Alignani D; Sagardoy A; Martinez-Ferrandis JI; Bunting KL; Meier S; Sagaert X; Bagnara D; Guruceaga E; Blanco O; Celay J; Martínez-Baztan A; Casares N; Lasarte JJ; MacCarthy T; Melnick A; Martinez-Climent JA; Roa S
    Blood; 2019 May; 133(22):2401-2412. PubMed ID: 30975638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphoma.
    Ying CY; Dominguez-Sola D; Fabi M; Lorenz IC; Hussein S; Bansal M; Califano A; Pasqualucci L; Basso K; Dalla-Favera R
    Nat Immunol; 2013 Oct; 14(10):1084-92. PubMed ID: 23974956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Ig/BCL6 translocations with germinal center B lymphocytes in human lymphoid tissues: implications for malignant transformation.
    Yang X; Lee K; Said J; Gong X; Zhang K
    Blood; 2006 Sep; 108(6):2006-12. PubMed ID: 16728698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CREBBP Acetyltransferase Is a Haploinsufficient Tumor Suppressor in B-cell Lymphoma.
    Zhang J; Vlasevska S; Wells VA; Nataraj S; Holmes AB; Duval R; Meyer SN; Mo T; Basso K; Brindle PK; Hussein S; Dalla-Favera R; Pasqualucci L
    Cancer Discov; 2017 Mar; 7(3):322-337. PubMed ID: 28069569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl6 middle domain repressor function is required for T follicular helper cell differentiation and utilizes the corepressor MTA3.
    Nance JP; Bélanger S; Johnston RJ; Hu JK; Takemori T; Crotty S
    Proc Natl Acad Sci U S A; 2015 Oct; 112(43):13324-9. PubMed ID: 26460037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Potential mechanism and prognostic value of promoter methylation of PRDM1 gene in diffuse large B cell lymphoma].
    Zhang XY; Ma ZP; Cui WL; Chen R; Glinaer A; Miao N; Li XX
    Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):831-837. PubMed ID: 28056297
    [No Abstract]   [Full Text] [Related]  

  • 18. The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis.
    Miyauchi Y; Ninomiya K; Miyamoto H; Sakamoto A; Iwasaki R; Hoshi H; Miyamoto K; Hao W; Yoshida S; Morioka H; Chiba K; Kato S; Tokuhisa T; Saitou M; Toyama Y; Suda T; Miyamoto T
    J Exp Med; 2010 Apr; 207(4):751-62. PubMed ID: 20368579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD137L and CD4 T cells limit BCL6-expressing pre-germinal center B cell expansion and BCL6-driven B cell malignancy.
    Ding Z; Quast I; Yan F; Liao Y; Pitt C; O-Donnell K; Robinson MJ; Shi W; Kallies A; Zotos D; Tarlinton DM
    Immunol Cell Biol; 2022 Oct; 100(9):705-717. PubMed ID: 35916066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes.
    Takahashi H; Feuerhake F; Kutok JL; Monti S; Dal Cin P; Neuberg D; Aster JC; Shipp MA
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3265-71. PubMed ID: 16740746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.